Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)
Public ClinicalTrials.gov record NCT07486960. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tulisokibart in Participants With Psoriatic Arthritis.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Researchers are looking for new ways to treat Psoriatic Arthritis (PsA). This study will help find out if a study medicine called tulisokibart (MK-7240) can treat symptoms of active PsA. This study assesses the efficacy, safety, and tolerability of tulisokibart in adult participants with active PsA. In this study, researchers will look at different doses of tulisokibart. Researchers want to learn if at least one of the study doses of tulisokibart works better than a placebo to lessen PsA symptoms. A placebo looks like the study medicine but has no study medicine in it. Using a placebo helps researchers better understand the effects of the study medicine.
Study identification
- NCT ID
- NCT07486960
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 140 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 20, 2026 (Actual)
- Primary completion
- Feb 17, 2027 (Estimated)
- Completion
- Jul 18, 2029 (Estimated)
- Last update posted
- Oct 20, 2026
2026 – 2029
United States locations
- U.S. sites
- 18
- U.S. states
- 12
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Arthritis & Rheumatology Associates, P.C. ( Site 5117) | Sun City | Arizona | 85351 | — |
| Arizona Arthritis & Rheumatology Associates, P.C. - Tucson ( Site 5120) | Tucson | Arizona | 85704-1140 | — |
| Medvin Clinical Research - Riverside ( Site 5115) | Riverside | California | 92508 | — |
| Cohen Medical Centers ( Site 5111) | Thousand Oaks | California | 91360 | — |
| Medvin Clinical Research - Tujunga ( Site 5113) | Tujunga | California | 91042 | — |
| Arthritis and Rheumatic Disease Specialties ( Site 5105) | Aventura | Florida | 33180 | — |
| International Center for Research ( Site 5124) | Tampa | Florida | 33618 | — |
| St. Luke's Clinic - Rheumatology - Boise ( Site 5109) | Boise | Idaho | 83702-4565 | — |
| Johns Hopkins University Division of Rheumatology ( Site 5132) | Baltimore | Maryland | 21224 | — |
| Arthritis and Rheumatism Associates - Rockville ( Site 5127) | Rockville | Maryland | 20850 | — |
| Kansas City Physician Partners ( Site 5119) | Kansas City | Missouri | 64111 | — |
| Physician Research Collaboration, LLC ( Site 5102) | Lincoln | Nebraska | 68516 | — |
| Joseph S. and Diane H. Steinberg Ambulatory Care Center ( Site 5106) | Brooklyn | New York | 11201 | — |
| Joint and Muscle Research Institute ( Site 5108) | Charlotte | North Carolina | 28204 | — |
| Altoona Center for Clinical Research ( Site 5110) | Duncansville | Pennsylvania | 16635 | — |
| Perelman Center for Advanced Medicine ( Site 5134) | Philadelphia | Pennsylvania | 19104 | — |
| Articularis Healthcare Group dba: Low Country Rheumatology ( Site 5128) | Summerville | South Carolina | 29486 | — |
| Greater Houston Rheumatology ( Site 5103) | Houston | Texas | 77095 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 32 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07486960, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 20, 2026 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07486960 live on ClinicalTrials.gov.